Corporate Overview Corporate Overview April 2024 April 23, 2024 Publications ZB-168 potently inhibits thymic stromal lymphopoietin mediated inflammation (#WAC23-0179) World Allergy Congress (WAC) December 2, 2023
ZB-168 potently inhibits thymic stromal lymphopoietin mediated inflammation (#WAC23-0179) World Allergy Congress (WAC) December 2, 2023